Comparison of the effects of labetalol and propranolol in healthy men at rest and during exercise
- PMID: 843418
- PMCID: PMC1428991
- DOI: 10.1111/j.1365-2125.1977.tb00660.x
Comparison of the effects of labetalol and propranolol in healthy men at rest and during exercise
Abstract
1. Oral labeltalol and propranolol have been compared in healthy men with regard to the effects on heart rate, blood pressure and peak expiratory flow rate (PEFR) at rest and the changes induced by exercise. 2. Labetalol caused a dose-related reduction in standing diastolic pressure at rest whereas propranolol did not but neither drug altered standing systolic pressure at rest. 3. In the doses compared, propranolol was consistently more potent than labetalol in influencing blood pressure changes induced by exercise, in lowering heart rate at rest and reducing PEFR at rest. 4. Labetalol and propranolol are both beta-adrenoreceptor antagonists and the observed differences in the profiles of the two drugs are probably directly related to the additional alpha-adrenoreceptor blocking property of labetalol not possessed by propranolol. Because of these differences labetalol may be expected to have advantages in the treatment of hypertension.
Similar articles
-
Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.Br J Clin Pharmacol. 1985 Apr;19(4):405-10. doi: 10.1111/j.1365-2125.1985.tb02662.x. Br J Clin Pharmacol. 1985. PMID: 2859871 Free PMC article. Clinical Trial.
-
Effects of labetalol and propranolol on blood pressure at rest and during isometric and dynamic exercise.Eur J Clin Pharmacol. 1979 Nov;16(5):299-303. doi: 10.1007/BF00605625. Eur J Clin Pharmacol. 1979. PMID: 520397 Clinical Trial.
-
Renal haemodynamics after chronic treatment with labetalol and propranolol.Br J Clin Pharmacol. 1982 Jun;13(1 Suppl):123S-126S. doi: 10.1111/j.1365-2125.1982.tb01900.x. Br J Clin Pharmacol. 1982. PMID: 7093095 Free PMC article. Clinical Trial.
-
Pharmacological effects of labetalol in man.Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):721-3. Br J Clin Pharmacol. 1976. PMID: 10949 Review.
-
A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):681-4. Br J Clin Pharmacol. 1976. PMID: 10948 Review.
Cited by
-
Bronchial and cardiac beta-adrenoceptor blockade--a comparison of atenolol, acebutolol and labetalol.Br J Clin Pharmacol. 1981 Jul;12(1):61-5. doi: 10.1111/j.1365-2125.1981.tb01855.x. Br J Clin Pharmacol. 1981. PMID: 6264936 Free PMC article.
-
Studies of cardioselectivity and partial agonist activity in beta-adrenoceptor blockade comparing effects on heart rate and peak expiratory flow rate during exercise.Br J Clin Pharmacol. 1978 Feb;5(2):107-20. doi: 10.1111/j.1365-2125.1978.tb01609.x. Br J Clin Pharmacol. 1978. PMID: 23136 Free PMC article. Clinical Trial.
-
Erythrocyte G protein as a novel target for malarial chemotherapy.PLoS Med. 2006 Dec;3(12):e528. doi: 10.1371/journal.pmed.0030528. PLoS Med. 2006. PMID: 17194200 Free PMC article.
-
Comparison of labetalol, propranolol and hydralazine in hypertensive out-patients.Eur J Clin Pharmacol. 1982;21(6):457-60. doi: 10.1007/BF00542038. Eur J Clin Pharmacol. 1982. PMID: 7042373 Clinical Trial.
-
Beta-blocking and electrophysiological effects of propafenone in volunteers.Eur J Clin Pharmacol. 1983;25(6):831-3. doi: 10.1007/BF00542530. Eur J Clin Pharmacol. 1983. PMID: 6662183
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources